Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00432-008-0534-8.

Title:
Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer | Journal of Cancer Research and Clinical Oncology
Description:
Introduction p16 INK4A is a tumor suppressor encoding the Cdk inhibitor protein, which acts to repress Cdk4/6 and pRb phosphorylation. p16 INK4A gene can be inactivated by a variety of events, including promoter hypermethylation. Materials and methods To investigate the methylation status of the p16 INK4A gene in Iranian patients with breast carcinoma, promoter methylation was studied by methylation-specific PCR (MSP) and restriction enzyme-related PCR (REP). In addition, p16 INK4A promoter was analyzed by PCR-SSCP in order to detection of mutation and single nucleotide polymorphisms. Results Analysis of 70 patients by MPS and REP showed hypermethylation of p16 INK4A promoter in 35.7% (25/70) and 40% (28/70) of samples, respectively. Comparison of the molecular data and pathological information of the samples suggested that p16 INK4A gene might be inactivated at the early stages in breast cancer. Conclusion Therefore, it could be suggested that hypermethylation of p16 INK4A promoter is one of the epigenetic factors affecting the progress of sporadic breast carcinogenesis in Iranian patients.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't tell how the site generates income.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {πŸ”}

google, scholar, cancer, article, cas, pubmed, breast, methylation, gene, human, inka, res, tumor, suppressor, hypermethylation, pinka, cell, dna, promoter, privacy, cookies, content, analysis, journal, research, iranian, patients, sporadic, vallian, carcinoma, silencing, expression, cells, nature, data, information, publish, search, status, sadeq, cdk, protein, pcr, epigenetic, access, genes, primary, herman, sci, clin,

Topics {βœ’οΈ}

month download article/chapter encoded p16-ink4a protein rep showed hypermethylation restriction enzyme-related pcr tumor suppressor encoding sadeq vallian tumor suppressor genes cdkn2/p16/mts1 gene silent p14/p16 locus p16 ink4a gene article vallian sporadic breast cancer p16 gene deletion tumor-suppressive functions metastatic breast carcinoma human cancer cells full article pdf human ink4a locus human breast cancer human primary tumors sporadic breast carcinogenesis sporadic breast tumors related subjects p16 ink4a promoter normal breast tissue p16 ink4a genes cancer-related genes privacy choices/manage cookies including promoter hypermethylation cpg island methylation clinical oncology aims msp author correspondence aberrant dna methylation mts-1/cdkn2/ink4a mdr1 promoter hypermethylation methylation-specific pcr methylation specific pcr epigenetics joins genetics dna demethylating agent single nucleotide polymorphisms check access instant access t-cell lymphomas increased gene expression cdk inhibitor protein common human cancers aberrant promoter methylation dna hypermethylation p16 gene

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer
         description: p16 INK4A is a tumor suppressor encoding the Cdk inhibitor protein, which acts to repress Cdk4/6 and pRb phosphorylation. p16 INK4A gene can be inactivated by a variety of events, including promoter hypermethylation. To investigate the methylation status of the p16 INK4A gene in Iranian patients with breast carcinoma, promoter methylation was studied by methylation-specific PCR (MSP) and restriction enzyme-related PCR (REP). In addition, p16 INK4A promoter was analyzed by PCR-SSCP in order to detection of mutation and single nucleotide polymorphisms. Analysis of 70 patients by MPS and REP showed hypermethylation of p16 INK4A promoter in 35.7% (25/70) and 40% (28/70) of samples, respectively. Comparison of the molecular data and pathological information of the samples suggested that p16 INK4A gene might be inactivated at the early stages in breast cancer. Therefore, it could be suggested that hypermethylation of p16 INK4A promoter is one of the epigenetic factors affecting the progress of sporadic breast carcinogenesis in Iranian patients.
         datePublished:2009-01-06T00:00:00Z
         dateModified:2009-01-06T00:00:00Z
         pageStart:991
         pageEnd:996
         sameAs:https://doi.org/10.1007/s00432-008-0534-8
         keywords:
            Breast cancer
            Hypermethylation
            Iranian population
            MSP
             p16 INK4A tumor suppressor gene
            REP
            Oncology
            Cancer Research
            Internal Medicine
            Hematology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-008-0534-8/MediaObjects/432_2008_534_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-008-0534-8/MediaObjects/432_2008_534_Fig2_HTML.gif
         isPartOf:
            name:Journal of Cancer Research and Clinical Oncology
            issn:
               1432-1335
               0171-5216
            volumeNumber:135
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sadeq Vallian
               affiliation:
                     name:The University of Isfahan
                     address:
                        name:Division of Genetics, Department of Biology, Faculty of Science, The University of Isfahan, Isfahan, Islamic Republic of Iran
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Mandana Sedaghat
               affiliation:
                     name:The University of Tehran
                     address:
                        name:Division of Cell and Molecular Biology, Faculty of Science, The University of Tehran, Tehran, Islamic Republic of Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Isar Nassiri
               affiliation:
                     name:The University of Isfahan
                     address:
                        name:Division of Genetics, Department of Biology, Faculty of Science, The University of Isfahan, Isfahan, Islamic Republic of Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ali Frazmand
               affiliation:
                     name:The University of Tehran
                     address:
                        name:Division of Cell and Molecular Biology, Faculty of Science, The University of Tehran, Tehran, Islamic Republic of Iran
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer
      description: p16 INK4A is a tumor suppressor encoding the Cdk inhibitor protein, which acts to repress Cdk4/6 and pRb phosphorylation. p16 INK4A gene can be inactivated by a variety of events, including promoter hypermethylation. To investigate the methylation status of the p16 INK4A gene in Iranian patients with breast carcinoma, promoter methylation was studied by methylation-specific PCR (MSP) and restriction enzyme-related PCR (REP). In addition, p16 INK4A promoter was analyzed by PCR-SSCP in order to detection of mutation and single nucleotide polymorphisms. Analysis of 70 patients by MPS and REP showed hypermethylation of p16 INK4A promoter in 35.7% (25/70) and 40% (28/70) of samples, respectively. Comparison of the molecular data and pathological information of the samples suggested that p16 INK4A gene might be inactivated at the early stages in breast cancer. Therefore, it could be suggested that hypermethylation of p16 INK4A promoter is one of the epigenetic factors affecting the progress of sporadic breast carcinogenesis in Iranian patients.
      datePublished:2009-01-06T00:00:00Z
      dateModified:2009-01-06T00:00:00Z
      pageStart:991
      pageEnd:996
      sameAs:https://doi.org/10.1007/s00432-008-0534-8
      keywords:
         Breast cancer
         Hypermethylation
         Iranian population
         MSP
          p16 INK4A tumor suppressor gene
         REP
         Oncology
         Cancer Research
         Internal Medicine
         Hematology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-008-0534-8/MediaObjects/432_2008_534_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-008-0534-8/MediaObjects/432_2008_534_Fig2_HTML.gif
      isPartOf:
         name:Journal of Cancer Research and Clinical Oncology
         issn:
            1432-1335
            0171-5216
         volumeNumber:135
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sadeq Vallian
            affiliation:
                  name:The University of Isfahan
                  address:
                     name:Division of Genetics, Department of Biology, Faculty of Science, The University of Isfahan, Isfahan, Islamic Republic of Iran
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Mandana Sedaghat
            affiliation:
                  name:The University of Tehran
                  address:
                     name:Division of Cell and Molecular Biology, Faculty of Science, The University of Tehran, Tehran, Islamic Republic of Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Isar Nassiri
            affiliation:
                  name:The University of Isfahan
                  address:
                     name:Division of Genetics, Department of Biology, Faculty of Science, The University of Isfahan, Isfahan, Islamic Republic of Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ali Frazmand
            affiliation:
                  name:The University of Tehran
                  address:
                     name:Division of Cell and Molecular Biology, Faculty of Science, The University of Tehran, Tehran, Islamic Republic of Iran
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Cancer Research and Clinical Oncology
      issn:
         1432-1335
         0171-5216
      volumeNumber:135
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The University of Isfahan
      address:
         name:Division of Genetics, Department of Biology, Faculty of Science, The University of Isfahan, Isfahan, Islamic Republic of Iran
         type:PostalAddress
      name:The University of Tehran
      address:
         name:Division of Cell and Molecular Biology, Faculty of Science, The University of Tehran, Tehran, Islamic Republic of Iran
         type:PostalAddress
      name:The University of Isfahan
      address:
         name:Division of Genetics, Department of Biology, Faculty of Science, The University of Isfahan, Isfahan, Islamic Republic of Iran
         type:PostalAddress
      name:The University of Tehran
      address:
         name:Division of Cell and Molecular Biology, Faculty of Science, The University of Tehran, Tehran, Islamic Republic of Iran
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sadeq Vallian
      affiliation:
            name:The University of Isfahan
            address:
               name:Division of Genetics, Department of Biology, Faculty of Science, The University of Isfahan, Isfahan, Islamic Republic of Iran
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Mandana Sedaghat
      affiliation:
            name:The University of Tehran
            address:
               name:Division of Cell and Molecular Biology, Faculty of Science, The University of Tehran, Tehran, Islamic Republic of Iran
               type:PostalAddress
            type:Organization
      name:Isar Nassiri
      affiliation:
            name:The University of Isfahan
            address:
               name:Division of Genetics, Department of Biology, Faculty of Science, The University of Isfahan, Isfahan, Islamic Republic of Iran
               type:PostalAddress
            type:Organization
      name:Ali Frazmand
      affiliation:
            name:The University of Tehran
            address:
               name:Division of Cell and Molecular Biology, Faculty of Science, The University of Tehran, Tehran, Islamic Republic of Iran
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Genetics, Department of Biology, Faculty of Science, The University of Isfahan, Isfahan, Islamic Republic of Iran
      name:Division of Cell and Molecular Biology, Faculty of Science, The University of Tehran, Tehran, Islamic Republic of Iran
      name:Division of Genetics, Department of Biology, Faculty of Science, The University of Isfahan, Isfahan, Islamic Republic of Iran
      name:Division of Cell and Molecular Biology, Faculty of Science, The University of Tehran, Tehran, Islamic Republic of Iran
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(134)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.28s.